The impact of solubility during pharmaceutical research and development
Posted on February 26, 2013
By: Christoph Saal, Head Of Analytical And Physico-chemical Characterisation
Merck KGaA
The key question: The role for solubility to ensure bioavailability Solubility has become a key parameter in pharmaceutical research and development as poor solubility is one of the main causes for poor bioavailability, and the fraction of poorly soluble compounds entering clinical development has ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
